Basiliximab Vs. rabbit antithymocyte globulin (rATG) induction in "low risk" Kidney transplantation in Colombia

被引：0
|
作者：
Salcedo, Sergio [1 ]
Giron, Fernando [1 ]
Baez, Yenny [1 ]
Nino-Murcia, Alejandro [1 ]
机构：
[1] Colombiana Trasplantes, Presidencia, Bogota, Colombia
来源：
TRANSPLANTATION | 2016年 / 100卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.1369
引用
收藏
页码：S646 / S647
页数：2
相关论文
共 50 条
  • [41] Comparison Between Horse and Rabbit Antithymocyte Globulin as an Induction Agent in Kidney Transplantation: A Single Center Experience
    Kim, J. M.
    Lee, S.
    Moon, H. H.
    Kim, T. -S.
    Song, S.
    Shin, M.
    Kwon, C. H. D.
    Kim, S. J.
    Joh, J. -W.
    Lee, S. -K.
    TRANSPLANTATION, 2012, 94 (10) : 973 - 973
  • [42] Alemtuzumab versus rabbit antithymocyte globulin induction in kidney and pancreas transplantation: A prospective randomized study.
    Farney, A.
    Rogers, J.
    Ashcroft, E.
    Hartmann, E.
    Hart, L.
    Doares, W.
    Moore, P.
    Jarrett, A.
    Sundberg, A.
    Adams, P.
    Stratta, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 233 - 233
  • [43] Assessment of rabbit antithymocyte globulin dosing and clinical outcomes in kidney transplantation
    Snyder, Heather
    Krauss, Amy
    Rao, Vinaya
    Ulrich, Dagney
    Duhart, Benjamin, Jr.
    PHARMACOTHERAPY, 2013, 33 (10): : E241 - E241
  • [44] Improved safety of basiliximab (Simulect®) over antithymocyte globulin (Thymoglobulin®) induction therapy in heart transplantation
    Mattei, M. F.
    Boissonnat, P.
    Redonnet, M.
    Gandjbakhch, I.
    Bandini, A. Mouly
    Dorent, R.
    Yan, C.
    Blanc, A. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S62 - S62
  • [45] COST-EFFECTIVENESS ANALYSIS OF RABBIT ANTITHYMOCYTE GLOBULIN COMPARED TO BASILIXIMAB IN THE INDUCTION OF RENAL TRANSPLANT PATIENTS
    Escudero, P.
    Misas, J. D.
    Orozco-Cabal, L. F.
    VALUE IN HEALTH, 2013, 16 (07) : A698 - A699
  • [46] Highly Sensitized Kidney Recipients (PRA>80%) Benefit from Rabbit Antithymocyte Globulin (rATG) and Rituximab Induction Therapy.
    Laftavi, M. R.
    Seepana, V.
    Alnimri, M.
    Patel, S.
    Kohli, R.
    Feng, L.
    Said, M.
    Pankewycz, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 487 - 488
  • [47] Correction to: Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience
    Hong-Feng Huang
    Jing-Yi Zhou
    Wen-Qing Xie
    Jian-Yong Wu
    Hao Deng
    Jiang-Hua Chen
    International Urology and Nephrology, 2019, 51 : 559 - 559
  • [48] HEALTH ECONOMIC ANALYSIS OF RABBIT ANTITHYMOCYTE GLOBULIN (THYMOGLOBULIN) VERSUS BASILIXIMAB IN RENAL TRANSPLANTATION - A GERMAN PERSPECTIVE
    Cremaschi, L.
    Thaiss, F.
    Thissen, R.
    Benzing, T.
    Milkovich, G.
    Paivanas, T.
    Reitan, J.
    Gallagher, M.
    Wiesener, M.
    Zink, N.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 57 - 57
  • [49] Nineteen Years Experience with Antithymocyte Globulin Induction in Kidney Pediatric Transplantation
    Mota, C.
    Martins, L.
    Costa, T.
    Faria, M. D. S.
    Henriques, A. Castro
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1894 - 1894
  • [50] Combined Induction Therapy with Rabbit Antithymocyte Globulin (rATG) and Rituximab (RTX) in Highly Sensitized Kidney Recipients: Long-Term Outcomes.
    Laftavi, M.
    Patel, S.
    Kohli, R.
    Zachariah, M.
    Feng, L.
    Said, M.
    Dayton, M.
    Pankewycz, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 427 - 427
12345